Sustained efficacy, safety and patient-reported outcomes of certolizumab pegol in axial spondyloarthritis: 4-year outcomes from RAPID-axSpA

OBJECTIVE: The aim was to assess the long-term safety and efficacy of certolizumab pegol over 4 years of continuous treatment in patients with axial spondyloarthritis (axSpA), including both AS and non-radiographic (nr-) axSpA. METHODS: RAPID-axSpA was a phase 3 randomized trial, double blind and pl...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Rheumatology (Oxford)
Autori principali: van der Heijde, Désirée, Dougados, Maxime, Landewé, Robert, Sieper, Joachim, Maksymowych, Walter P., Rudwaleit, Martin, Van den Bosch, Filip, Braun, Jürgen, Mease, Philip J., Kivitz, Alan J., Walsh, Jessica, Davies, Owen, Bauer, Lars, Hoepken, Bengt, Peterson, Luke, Deodhar, Atul
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2017
Soggetti:
Clinical Science
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5850296/
https://ncbi.nlm.nih.gov/pubmed/28498975
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/rheumatology/kex174
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi